Latest Ratings for HLNE Date Firm Action From To Jan 2022 Morgan Stanley Maintains Equal-Weight Dec 2021 Wells Fargo Initiates Coverage On Equal-Weight Oct 2021 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for HLNE View the Latest Analyst Ratings read more
Latest Ratings for SRE Date Firm Action From To Mar 2022 Keybanc Downgrades Overweight Sector Weight Feb 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for SRE View the Latest Analyst Ratings read more
Latest Ratings for AEE Date Firm Action From To Feb 2022 Wells Fargo Maintains Overweight Feb 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for AEE View the Latest Analyst Ratings read more
Latest Ratings for EXE Date Firm Action From To Mar 2022 RBC Capital Maintains Sector Perform Apr 2020 CIBC Downgrades Outperformer Neutral View More Analyst Ratings for EXE View the Latest Analyst Ratings read more
Latest Ratings for TPG Date Firm Action From To Feb 2022 BMO Capital Initiates Coverage On Market Perform Feb 2022 Keefe, Bruyette & Woods Initiates Coverage On Market Perform Feb 2022 Evercore ISI Group Initiates Coverage On In-Line View More Analyst Ratings for TPG View the Latest Analyst Ratings read more
Latest Ratings for AKAM Date Firm Action From To Feb 2022 Citigroup Maintains Buy Feb 2022 Raymond James Maintains Outperform Jan 2022 Keybanc Upgrades Sector Weight Overweight View More Analyst Ratings for AKAM View the Latest Analyst Ratings read more
Market volatility has led to re-evaluation of risk management. Buffered ETFs, like TrueShares Structured Outcome ETF, offer downside protection and upside potential. CEO of TrueMark Investments explains why these ETFs are in demand. read more
Bitcoin (CRYPTO: BTC) critic Peter Schff is warning that the strategic Bitcoin reserve is a tool to trick Americans into speculative losses. read more
Although Salesforce has encountered macroeconomic headwinds, the smart money is sniffing out a recovery play in CRM stock. read more
